Cryo-Save acquires Salus Futura
Cryo-Save Group NV, a Holland-based stem cell bank, has agreed to acquire Italian rival Salus Futura Srl, for up to €400,000 (£348,000) in cash.
News
Cryo-Save Group NV, a Holland-based stem cell bank, has agreed to acquire Italian rival Salus Futura Srl, for up to €400,000 (£348,000) in cash.
News
News